No Data
No Data
TG Therapeutics (NASDAQ:TGTX) Delivers Shareholders Solid 15% CAGR Over 5 Years, Surging 6.6% in the Last Week Alone
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But on a lighter note, a good company can see its share price rise well
Insider Sale: Director Sagar Lonial Sells 25,933 Shares of TG Therapeutics Inc (TGTX)
TG Therapeutics(TGTX.US) Director Sells US$432.89K in Common Stock
$TG Therapeutics(TGTX.US)$ Director Lonial Sagar sold 25,933 shares of common stock on Jun 17, 20, 2024 at an average price of $16.69 for a total value of $432.89K.Source: Announcement What is stateme
Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises
PALM BEACH, Fla., June 11, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - In the last twenty years, the amount of people with multiple sclerosis (MS) in the United States has more than doubled. In 2000, it
Express News | Calstrs: Decided to Vote Against Laurence Charney, Yann Echelard, Kenneth Hoberman, Daniel Hume, Sagar Loniel, Michael Weiss at TG Therapeutics' AGM
TG Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
PDF Version Fireside chat scheduled for Tuesday, June 11, 2024, at 1:20 PM ETNEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Wei